cMRI Now Available Through TeraRecon’s Eureka Clinical AI Platform
cMRI is now available through TeraRecon's Eureka Clinical AI platform, an AI solution for imaging analysis spanning neurology, oncology, pulmonology, and cardiology.
Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA
New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.
Fountain Health Announces Full Coverage On Neurological Imaging
Fountain Health announces 100 percent coverage of Combinostics cMRI and cDSI. The company is now the first and only health insurance platform to provide complete coverage for the AI-enabled neurological imaging and decision support solutions.
Combinostics Adds Industry Experts to Leadership Team
Dr. Erik Post and Dr. Hans-Peter Huber have joined Combinostics as Group Chief Financial Officer (CFO) and Vice President of European Sales, respectively. Their contributions include considerable experience scaling software solutions.
Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)
cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.
Combinostics Launches Latest Version of Its cNeuro Platform
The latest version of cNeuro® includes the launch of the Dementia Differential Analysis report, new disease-specific reports, additional automated MRI quantifications and imaging biomarkers, and more.
Combinostics Announces an Industry-First Report Supporting the Differential Diagnosis of Dementias
Our industry-first Dementia Differential Analysis report is based on MRI data only and compares the patient’s data against reference data from thousands of previous patients.
Tom Gardner Joins Combinostics as Vice President of US Sales
Tom Gardner has joined Combinostics as the Vice President of US Sales. He has over 25 years of experience successfully developing and leading sales teams in the AI and clinical imaging software solutions space.
Combinostics Selected to Progress to the Finals of neurotechprize
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
Combinostics Not Impacted by Apache Log4j Vulnerability
We are confident that Combinostics is not affected by the recent vulnerabilities found in Apache Log4j. We will continue to track updates relating to this vulnerability.
